Dinuclear Ru(II) Complexes for Synergetic Photodynamic, Photothermal, and Sonodynamic Therapy against Cisplatin-Resistant Cancer
Inorganic Chemistry · 2025
DOI: 10.1021/acs.inorgchem.5c00558 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inorganic Chemistry, 2025. Verfasst von Xiao-Xia Ren und 9 weiteren Autor:innen. Beteiligte Einrichtung: Animal Research and Resource Center, School of Life Sciences, Yunnan University, Kunming 650500, P. R. China. Hauptthemen laut MEDLINE: Coordination Complexes, Antineoplastic Agents, Ruthenium, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: Yunan Ten Thousand Talents Plan Young and Elite Talents Project, Yunnan Provincial Science and Technology Department, National Natural Science Foundation of China.
Abstract (Originalsprache)
A new series of dinuclear Ru(II) complexes with a novel bridging ligand were developed for the treatment of cisplatin-resistant non-small-cell lung cancer via a synergistic photodynamic, photothermal, and sonodynamic therapy mechanism. Comprehensive experimental and theoretical studies investigated their photophysical and photochemical properties along with the influence of ancillary ligands. The complexes exhibit significant two-photon absorption at the IR region, facilitating ROS generation through both type I and II mechanisms under IR laser and ultrasound exposure. They effectively target mitochondria and nuclei, regulating DNA-related mechanisms, including the inhibition of DNA topoisomerase and RNA polymerase while promoting photoactivated apoptosis and ferroptosis. The high synergy effect between IR and ultrasound was attributed to the rise in oxygen availability via ultrasound-induced cavitation and a thermal-induced increase in vascular permeability and oxygen partial pressure. In vivo experiments confirmed that the combination of IR and ultrasound yielded superior therapeutic outcomes compared with single-modality treatments. The tested complex exhibited excellent safety with rapid in vivo clearance and low toxicity to normal cells. These findings suggest that IR-activated metal complexes can significantly advance integrated diagnostic and therapeutic approaches, overcoming challenges such as drug resistance and hypoxic environments in deep tumors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Animal Research and Resource Center, School of Life Sciences, Yunnan University, Kunming 650500, P. R. China.
- Key Laboratory of Medicinal Chemistry for Natural Resource, Ministry of Education; Yunnan Provincial Center for Research & Development of Natural Products; School of Pharmacy, Yunnan University, Kunming 650500, P. R. Ch…
ORCID-Profile: Feng Gao
Förderung
- Yunan Ten Thousand Talents Plan Young and Elite Talents Project
- Yunnan Provincial Science and Technology Department
- National Natural Science Foundation of China
Zitieren
APA
Ren, X. X., Li, X. L., Zhao, R. Y., Li, Y., Song, R., Han, M. C., Yan, Y. F., Zeng, L. Z., Cai, Z. Y., & Gao, F. (2025). Dinuclear Ru(II) Complexes for Synergetic Photodynamic, Photothermal, and Sonodynamic Therapy against Cisplatin-Resistant Cancer. Inorganic Chemistry. https://doi.org/10.1021/acs.inorgchem.5c00558
Vancouver
Ren XX, Li XL, Zhao RY, Li Y, Song R, Han MC, et al. Dinuclear Ru(II) Complexes for Synergetic Photodynamic, Photothermal, and Sonodynamic Therapy against Cisplatin-Resistant Cancer. Inorganic Chemistry. 2025. doi:10.1021/acs.inorgchem.5c00558
BibTeX
@article{Ren2025,
author = {Ren, Xiao-Xia and Li, Xue-Lian and Zhao, Run-Yu and Li, Yun and Song, Ran and Han, Meng-Chi and Yan, Yu-Fei and Zeng, Li-Zhen and Cai, Zhong-Yan and Gao, Feng},
title = {Dinuclear Ru(II) Complexes for Synergetic Photodynamic, Photothermal, and Sonodynamic Therapy against Cisplatin-Resistant Cancer},
journal = {Inorganic Chemistry},
year = {2025},
doi = {10.1021/acs.inorgchem.5c00558}
}
EUVIMED